Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura (TTP) is a rare, serious blood disorder where tiny blood clots form in small blood vessels throughout the body. These clots use up platelets (tiny blood cells that help blood clot) and damage red blood cells. This can lead to bleeding, anemia, and organ damage, requiring urgent medical care.

What is Thrombotic Thrombocytopenic Purpura?

Thrombotic Thrombocytopenic Purpura (TTP) is a rare and life-threatening blood disorder where small blood clots form in tiny blood vessels throughout the body. These clots consume platelets, leading to a low platelet count (thrombocytopenia), and damage red blood cells, causing a type of anemia. TTP can quickly lead to organ damage if not treated promptly.

TTP is characterized by a combination of problems: blood clots (thrombotic), a low number of platelets (thrombocytopenic), and purple spots on the skin (purpura) due to bleeding. The small blood clots can block blood flow to organs like the brain, kidneys, and heart, potentially causing serious damage. The core issue in TTP is a problem with an enzyme called ADAMTS13. This enzyme normally helps break down a large protein called von Willebrand factor, which is involved in blood clotting. When ADAMTS13 is missing or not working correctly, von Willebrand factor becomes too large, causing platelets to clump together abnormally and form widespread clots. These clots not only block blood vessels but also trap and destroy red blood cells, leading to a type of anemia called hemolytic anemia. The process also uses up a large number of platelets, which are essential for normal blood clotting, increasing the risk of bleeding elsewhere in the body.

Symptoms

Symptoms of Thrombotic Thrombocytopenic Purpura (TTP) can appear suddenly and vary widely, often including signs of bleeding, anemia, and organ problems. Common signs are purple spots or bruises on the skin (purpura), pale skin, extreme tiredness, fever, and neurological changes like confusion or headaches.

The symptoms of TTP can develop quickly and may include a range of issues affecting different body systems. Because platelets are low, you might notice unusual bleeding. This can appear as tiny red or purple spots on the skin (petechiae), larger bruises (purpura), nosebleeds, or bleeding gums. Damage to red blood cells causes anemia, leading to symptoms like extreme tiredness (fatigue), weakness, pale skin, and shortness of breath. The destruction of red blood cells can also cause yellowing of the skin or eyes (jaundice). Clots in the brain can cause neurological symptoms such as headaches, confusion, difficulty speaking, vision changes, seizures, or even a stroke. Other common symptoms include fever, abdominal pain, nausea, vomiting, and diarrhea. If clots affect the kidneys, you might notice changes in your urine output or experience kidney problems.

Causes & risk factors

Thrombotic Thrombocytopenic Purpura (TTP) is usually caused by a problem with an enzyme called ADAMTS13, which helps prevent blood clots. In most cases, the body's immune system mistakenly attacks and blocks this enzyme (acquired TTP). Less commonly, TTP is inherited due to a genetic defect affecting ADAMTS13.

The main cause of TTP is a severe deficiency or malfunction of the ADAMTS13 enzyme. This enzyme is crucial for regulating blood clotting. Without enough active ADAMTS13, platelets clump together excessively, forming clots in small blood vessels. Most cases of TTP are acquired, meaning they develop later in life. In acquired TTP, the immune system produces antibodies that attack and inhibit the ADAMTS13 enzyme. The exact reason why the immune system starts doing this is often unknown, but it can sometimes be triggered by certain conditions or medications. Less commonly, TTP is inherited (congenital TTP or Upshaw-Schulman syndrome). This form is caused by a genetic mutation that leads to a lifelong deficiency of the ADAMTS13 enzyme from birth. Risk factors for acquired TTP include being female, of African American descent, having certain autoimmune diseases (like lupus), pregnancy, some cancers, HIV infection, organ transplantation, or using certain medications (such as ticlopidine, clopidogrel, quinine, cyclosporine, or tacrolimus).

How it's diagnosed

Diagnosing Thrombotic Thrombocytopenic Purpura (TTP) involves a combination of blood tests and a review of your symptoms. Doctors look for a low platelet count, damaged red blood cells, and importantly, very low activity of the ADAMTS13 enzyme. Early and accurate diagnosis is critical for starting timely treatment.

Diagnosing TTP can be challenging because its symptoms can mimic other conditions. A doctor will typically start with a physical exam and a thorough review of your medical history and symptoms. Blood tests are essential for confirming a diagnosis. Key blood tests include a complete blood count (CBC), which will show a low platelet count (thrombocytopenia) and anemia (low red blood cells). A blood smear will be examined under a microscope to look for fragmented red blood cells, called schistocytes, which are a hallmark of TTP. Tests for kidney and liver function may also be performed to check for organ damage. The most specific test for TTP measures the activity of the ADAMTS13 enzyme. In TTP, ADAMTS13 activity is usually very low, often less than 10% of normal. Doctors may also test for antibodies that block ADAMTS13, which helps confirm acquired TTP. Rapid diagnosis is crucial because TTP is a medical emergency requiring immediate treatment.

Treatment options

The primary treatment for Thrombotic Thrombocytopenic Purpura (TTP) is plasma exchange (plasmapheresis), a procedure that removes harmful antibodies and replaces them with healthy plasma. Other treatments include medications to suppress the immune system or prevent clots, aiming to restore ADAMTS13 activity and prevent organ damage.

TTP is a medical emergency, and treatment must begin as soon as possible, often before a definitive diagnosis is fully confirmed. The cornerstone of treatment for acquired TTP is plasma exchange, also known as plasmapheresis. During this procedure, your blood is drawn, and the plasma (the liquid part of your blood containing the harmful antibodies) is removed and replaced with healthy donor plasma, which contains functional ADAMTS13 enzyme. This process is typically performed daily until your platelet count normalizes and other signs of TTP improve. In addition to plasma exchange, medications are often used. Corticosteroids, such as prednisone, are frequently given to suppress the immune system and reduce antibody production. Rituximab, a medication that targets specific immune cells (B cells), may also be used to help prevent the body from making antibodies against ADAMTS13. A newer medication, caplacizumab, may be used in combination with plasma exchange and immunosuppressants. It works by blocking von Willebrand factor, which helps prevent platelets from clumping together. For inherited TTP, regular infusions of plasma (which contains ADAMTS13) are typically needed throughout life to prevent episodes.

Recovery & outlook

With prompt and appropriate treatment, most people with acquired Thrombotic Thrombocytopenic Purpura (TTP) can recover. However, TTP can recur, so ongoing monitoring is essential. The outlook for inherited TTP often involves lifelong management with regular plasma infusions to prevent episodes.

Without treatment, TTP is often fatal. However, with modern treatments, especially plasma exchange, the outlook has significantly improved. Most people with acquired TTP who receive timely treatment can achieve remission, meaning their symptoms resolve and blood counts return to normal. Despite successful initial treatment, TTP can recur. About 30% to 50% of people with acquired TTP may experience a relapse, sometimes months or years after their initial recovery. Because of this risk, ongoing monitoring with regular blood tests and follow-up appointments with a hematologist (a blood disorder specialist) are crucial. Even after recovery, some individuals may experience long-term complications or lingering effects, such as chronic fatigue, memory problems, depression, high blood pressure, or kidney issues. For those with inherited TTP, lifelong management with regular plasma infusions is typically necessary to prevent TTP episodes and maintain health.

When to see a doctor

Seek immediate medical attention if you experience sudden, unexplained symptoms like unusual bruising or tiny red spots on your skin, extreme fatigue, pale skin, confusion, severe headaches, or changes in your vision or speech. These could be signs of Thrombotic Thrombocytopenic Purpura (TTP) or another serious blood disorder requiring urgent diagnosis and treatment.

TTP is a medical emergency. If you or someone you know develops symptoms that could suggest TTP, it is vital to seek emergency medical care right away. Do not wait to see if symptoms improve. Specific red-flag symptoms that warrant immediate medical attention include: * New, unexplained bruising or tiny red or purple spots (petechiae) on the skin. * Extreme tiredness, weakness, or pale skin that comes on suddenly. * Any neurological changes, such as confusion, difficulty speaking, vision changes, severe headaches, or seizures. * Fever without an obvious cause. * Yellowing of the skin or eyes (jaundice). * Dark or bloody urine. * Severe abdominal pain. Early diagnosis and prompt treatment are critical for improving the outcome of TTP and preventing severe organ damage or life-threatening complications.

Frequently asked questions

Is TTP a type of cancer?

No, Thrombotic Thrombocytopenic Purpura (TTP) is not a cancer. It is a rare blood disorder, usually caused by an autoimmune problem where the body mistakenly attacks an enzyme needed for blood clotting. It is not characterized by uncontrolled cell growth like cancer.

Can TTP be cured?

Acquired TTP can often be managed effectively, leading to remission, where symptoms resolve and blood counts normalize. However, it can recur, so ongoing monitoring is essential. Inherited TTP requires lifelong management with regular treatments to prevent episodes, rather than a cure.

How rare is TTP?

Thrombotic Thrombocytopenic Purpura (TTP) is very rare. It affects only a few people per million each year, making it one of the less common blood disorders.

What is the difference between TTP and HUS?

Both TTP and Hemolytic Uremic Syndrome (HUS) involve blood clots, low platelets, and red blood cell damage. However, TTP is primarily due to a severe deficiency of the ADAMTS13 enzyme, while HUS is often linked to kidney failure and infections, particularly E. coli bacteria.

Can TTP affect pregnancy?

Yes, pregnancy can be a trigger for acquired TTP, and it can also complicate existing TTP. Close medical monitoring and specialized care are essential for pregnant individuals with TTP to manage the condition and ensure the health of both mother and baby.

What are the long-term effects of TTP?

Even after recovering from an acute episode, some people with TTP may experience long-term effects. These can include chronic fatigue, memory problems, depression, high blood pressure, or kidney issues. Regular follow-up care is important for managing these potential complications.

Sources

• MedlinePlus — Thrombotic Thrombocytopenic Purpura
• Mayo Clinic — Thrombotic Thrombocytopenic Purpura
• Cochrane Library — Thrombotic Thrombocytopenic Purpura